I'm sorry guys, but Occulus does have a point.
How many 17 year olds do you know who can afford the (predicted) amount of at least $1,000 to get "immunized"? Do you think their parents are honestly going to pay for it or give them the "oh sweetie, you've got a loooong time before you have to worry about that" and by the time they have the funds on their own to afford it, they've gone up several Norwoods and a treatment that provides only maintenance, even if indefinite, is not worth it at that point.
The teenagers aiming to forever dodge baldness is not a reliable demographic.
It's interesting that Occulus has spun a 180 on this despite worrying that such a treatment would prevent others from coming to market, but hey...
It does seem that they intend to release it anyway, I do think there'll be a market for it, so I think the doom and gloom is unwarranted, but much like a broken clock is right twice a day, if we're to glean "maintenance isn't as attractive to the general public as the forums believe" off his posts, it's actually pretty hard to argue that.
After all, Aderan's treatment was capable of doing what this tech does and the company and investors swiftly shelved it.